Handbook for Investors. Business location in Switzerland.
Handbook for Investors. Business location in Switzerland.
Handbook for Investors. Business location in Switzerland.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Of the total CHF 13.1 billion spent on research and development<br />
<strong>in</strong> 2004, 70 % was f<strong>in</strong>anced by the private sector. The pharmaceutical<br />
<strong>in</strong>dustry had the highest expenditure at CHF 3.6 billion.<br />
The comb<strong>in</strong>ed R&D expenses of all universities and research <strong>in</strong>stitutes<br />
amounted to CHF 3 billion <strong>in</strong> 2004. Some 52,000 people are<br />
<strong>in</strong>volved <strong>in</strong> research, and 33,000 of these are <strong>in</strong> private <strong>in</strong>dustry.<br />
Fig. 62: Total per capita expenditure on research and<br />
development <strong>in</strong> USD (2006)<br />
1 Sweden 1,609<br />
2 <strong>Switzerland</strong>** 1,426<br />
3 F<strong>in</strong>land 1,373<br />
4 Luxembourg 1,358<br />
5 Denmark 1,237<br />
6 Japan 1,161<br />
7 US 1,135<br />
11 Germany 896<br />
12 France 774<br />
14 S<strong>in</strong>gapore 716<br />
15 UK 705<br />
16 Belgium 692<br />
17 Ireland 684<br />
18 Netherlands 684<br />
22 Italy 333<br />
27 Hong Kong SAR* 206<br />
33 Russia 74<br />
40 Brazil* 40<br />
43 People’s Republic of Ch<strong>in</strong>a 29<br />
51 India** 4<br />
Data from * 2005 ** 2004<br />
Source: 2009 IMD World Competitiveness Yearbook<br />
Fig. 63: Nobel prizes per million <strong>in</strong>habitants (2007)<br />
1 <strong>Switzerland</strong> 1.59<br />
2 Norway 1.27<br />
3 Sweden 0.98<br />
4 UK 0.87<br />
5 US 0.81<br />
6 Denmark 0.73<br />
8 Netherlands 0.43<br />
9 Germany 0.37<br />
13 Belgium 0.28<br />
14 France 0.27<br />
15 Ireland 0.23<br />
19 Italy 0.08<br />
20 Japan 0.07<br />
21 Russia 0.06<br />
24 People’s Republic of Ch<strong>in</strong>a 0.00<br />
25 India 0.00<br />
26 Luxembourg 0.00<br />
26 S<strong>in</strong>gapore 0.00<br />
26 Hong Kong SAR 0.00<br />
26 Brazil 0.00<br />
Source: 2009 IMD World Competitiveness Yearbook<br />
Government fund<strong>in</strong>g is provided pr<strong>in</strong>cipally <strong>for</strong> basic research.<br />
The private sector and the scientific community work closely<br />
together. Each <strong>in</strong>stitute at the university and college level has a<br />
coord<strong>in</strong>ation office <strong>for</strong> cooperation with the private sector. The<br />
CTI Innovation Promotion Agency can make significant f<strong>in</strong>ancial<br />
contributions to research and development projects <strong>in</strong> which<br />
companies cooperate with non-profit research organizations.<br />
Fig. 64: Research <strong>in</strong>stitutions <strong>in</strong> <strong>Switzerland</strong><br />
Institution Location Homepage<br />
CERN European Organization <strong>for</strong> Nuclear Research Geneva www.cern.ch<br />
English, French<br />
EAWAG Swiss Federal Institute of Aquatic<br />
Science and Technology<br />
Dübendorf (Zurich),<br />
Kastanienbaum (Lucerne)<br />
www.eawag.ch<br />
German, English<br />
EMPA Materials Science and Technology Research Institution Thun (Berne), Dübendorf<br />
(Zurich), St. Gallen<br />
www.empa.ch<br />
German, English, French<br />
PSI Paul Scherrer Institute Villigen (Aargau) www.psi.ch<br />
German, English<br />
118 <strong>Handbook</strong> <strong>for</strong> <strong>Investors</strong> 2010
Change language